Simonetta Buglioni

3.0k total citations
71 papers, 1.7k citations indexed

About

Simonetta Buglioni is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Simonetta Buglioni has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 34 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Simonetta Buglioni's work include Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (11 papers) and HER2/EGFR in Cancer Research (10 papers). Simonetta Buglioni is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (11 papers) and HER2/EGFR in Cancer Research (10 papers). Simonetta Buglioni collaborates with scholars based in Italy, Malaysia and United States. Simonetta Buglioni's co-authors include Marcella Mottolese, Douglas M. Noonan, Roberta Mortarini, Adriana Albini, Monica Morini, Nicoletta Ferrari, Gabriella Zupi, Carmen D’Angelo, Maurizio Cosimelli and Donatella Del Bufalo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Simonetta Buglioni

67 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simonetta Buglioni Italy 22 930 772 511 227 188 71 1.7k
Cameron N. Johnstone Australia 24 1.1k 1.2× 555 0.7× 445 0.9× 165 0.7× 324 1.7× 38 1.7k
Heini Lassus Finland 25 1.0k 1.1× 830 1.1× 555 1.1× 179 0.8× 184 1.0× 44 2.0k
Patricia M. McGowan Ireland 22 1.1k 1.2× 1.3k 1.7× 682 1.3× 294 1.3× 245 1.3× 33 2.3k
Xavier Sanjuán Spain 20 839 0.9× 667 0.9× 359 0.7× 250 1.1× 278 1.5× 55 1.7k
Wiam Bshara United States 25 811 0.9× 746 1.0× 402 0.8× 328 1.4× 314 1.7× 73 1.7k
Minji Jo United States 23 1.6k 1.7× 796 1.0× 902 1.8× 203 0.9× 444 2.4× 33 2.5k
Kazushi Shigemasa Japan 27 840 0.9× 636 0.8× 441 0.9× 98 0.4× 271 1.4× 50 1.8k
Iwan Beuvink Switzerland 11 1.1k 1.2× 840 1.1× 304 0.6× 204 0.9× 169 0.9× 13 1.7k
Leticia Oliveira‐Ferrer Germany 25 1.4k 1.5× 712 0.9× 645 1.3× 362 1.6× 458 2.4× 76 2.3k
Isabel Chu United States 11 1.1k 1.2× 1.0k 1.3× 346 0.7× 213 0.9× 135 0.7× 12 1.8k

Countries citing papers authored by Simonetta Buglioni

Since Specialization
Citations

This map shows the geographic impact of Simonetta Buglioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simonetta Buglioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simonetta Buglioni more than expected).

Fields of papers citing papers by Simonetta Buglioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simonetta Buglioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simonetta Buglioni. The network helps show where Simonetta Buglioni may publish in the future.

Co-authorship network of co-authors of Simonetta Buglioni

This figure shows the co-authorship network connecting the top 25 collaborators of Simonetta Buglioni. A scholar is included among the top collaborators of Simonetta Buglioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simonetta Buglioni. Simonetta Buglioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guerini‐Rocco, Elena, Simonetta Buglioni, Fabio Pagni, et al.. (2025). Part II – Analytical phase. Pathologica. 117(2). 18–18. 1 indexed citations
2.
Buglioni, Simonetta, Fabio Pagni, Nicola Fusco, et al.. (2025). Part III – Post-analytical phase. Pathologica. 117(2). 36–36. 1 indexed citations
3.
Rapa, Ida, Francesca Bertola, Gaia Roversi, et al.. (2025). Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non–Small-Cell Lung Cancer. Journal of Molecular Diagnostics. 27(5). 371–382.
4.
Gallina, Filippo Tommaso, Daniele Marinelli, Paolo Visca, et al.. (2025). TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. European Journal of Cancer. 227. 115622–115622.
5.
Lucianò, Anna Maria, Marta Di Martile, Ana B. Pérez‐Oliva, et al.. (2023). Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment. Journal of Experimental & Clinical Cancer Research. 42(1). 178–178. 8 indexed citations
6.
Marinelli, Daniele, Enrico Melis, Simonetta Buglioni, et al.. (2023). KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma. Lung Cancer. 181. 107254–107254. 8 indexed citations
7.
Normanno, Nicola, José Carlos Machado, Edoardo Pescarmona, et al.. (2023). European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors. International Journal of Molecular Sciences. 24(18). 13788–13788. 2 indexed citations
8.
Bazzichetto, Chiara, Michèle Milella, Francesca Simionato, et al.. (2022). Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker. Biomedicines. 10(10). 2631–2631. 19 indexed citations
9.
Gallina, Filippo Tommaso, Luca Bertolaccini, Shehab Mohamed, et al.. (2022). Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review. Cancers. 14(8). 1949–1949. 6 indexed citations
10.
Ercolani, Cristiana, Anna Di Benedetto, Paolo Visca, et al.. (2021). Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available. Journal of Clinical Pathology. 75(12). 844–850. 2 indexed citations
11.
Joshi, Molishree, Ahwan Pandey, Martı́n C. Abba, et al.. (2021). USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer. Oncogenesis. 10(3). 28–28. 19 indexed citations
12.
Marchetti, Antonio, Mattia Barbareschi, Massimo Barberis, et al.. (2021). Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network. Pathologica. 113(4). 262–271. 12 indexed citations
13.
Grassilli, Silvia, Federica Brugnoli, Rossano Lattanzio, Simonetta Buglioni, & Valeria Bertagnolo. (2020). Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer. Biomedicines. 8(10). 379–379. 8 indexed citations
14.
Ercolani, Cristiana, Caterina Marchiò, Anna Di Benedetto, et al.. (2017). Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification. Journal of Experimental & Clinical Cancer Research. 36(1). 143–143. 2 indexed citations
15.
Ercolani, Cristiana, Anna Di Benedetto, Irene Terrenato, et al.. (2017). Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy. Cancer Biology & Therapy. 18(5). 339–346. 15 indexed citations
16.
Fabi, Alessandra, Anna Di Benedetto, Giulio Metro, et al.. (2011). HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care. Clinical Cancer Research. 17(7). 2055–2064. 72 indexed citations
17.
Novelli, Flavia, Michele Stanislaw Milella, Elisa Melucci, et al.. (2008). A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. Breast Cancer Research. 10(5). R74–R74. 86 indexed citations
18.
19.
Mottolese, Marcella, Claudio Botti, Anna Maria Cianciulli, et al.. (2004). Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer. Journal of Cellular Physiology. 204(1). 106–112. 15 indexed citations
20.
Biroccio, Annamaria, Barbara Benassi, Igea D’Agnano, et al.. (2001). c-Myb and Bcl-x Overexpression Predicts Poor Prognosis in Colorectal Cancer. American Journal Of Pathology. 158(4). 1289–1299. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cameron N. Johnstone Breakdown of academic impact, for papers by Heini Lassus Breakdown of academic impact, for papers by Patricia M. McGowan Breakdown of academic impact, for papers by Xavier Sanjuán Breakdown of academic impact, for papers by Wiam Bshara Breakdown of academic impact, for papers by Minji Jo Breakdown of academic impact, for papers by Kazushi Shigemasa Breakdown of academic impact, for papers by Iwan Beuvink Breakdown of academic impact, for papers by Leticia Oliveira‐Ferrer Breakdown of academic impact, for papers by Isabel Chu
Rankless by CCL
2026